{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:06:22Z","timestamp":1749632782323},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1007\/bf01324837","type":"journal-article","created":{"date-parts":[[2005,3,26]],"date-time":"2005-03-26T02:03:58Z","timestamp":1111802638000},"page":"69-76","source":"Crossref","is-referenced-by-count":4,"title":["Cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Hidemitsu","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Izumimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tsuruzono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1341","volume":"64","author":"R Jager De","year":"1980","unstructured":"De Jager R, Longeval E, Klastersky J: High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: A phase II clinical trial of the EORTC lung cancer working party (Belgium). Cancer Treat Rep 64: 1341?1346, 1980","journal-title":"Cancer Treat Rep"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/1097-0142(19820701)50:1<24::AID-CNCR2820500106>3.0.CO;2-R","volume":"50","author":"SE Vogl","year":"1982","unstructured":"Vogl SE, Berenzweig M, Camacho F, Greenwald E, Kaplan BH: Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinoma. Cancer 50: 24?26, 1982","journal-title":"Cancer"},{"key":"CR3","first-page":"375","volume":"66","author":"VK Bhuchar","year":"1982","unstructured":"Bhuchar VK, Lanzotti VJ: High-dose cisplatin for lung cancer. Cancer Treat Rep 66: 375?376, 1982","journal-title":"Cancer Treat Rep"},{"key":"CR4","first-page":"1207","volume":"62","author":"JC Britell","year":"1978","unstructured":"Britell JC, Eagan RT, Ingle JN, Creagan ET, Rubin J, Frytak S: Cis-dichlorodiammine (II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichloro-diammine-platinum (II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung. Cancer Treat Rep 62: 1207?1210, 1978","journal-title":"Cancer Treat Rep"},{"key":"CR5","first-page":"2107","volume":"63","author":"ES Casper","year":"1979","unstructured":"Casper ES, Gralla RJ, Kelsen DP, Cvitkovic E, Golbey RB: Phase II study of high-dose cis-dichlorodiammineplatinum (II) in the treatment of non-small cell lung cancer. Cancer Treat Rep 63: 2107?2109, 1979","journal-title":"Cancer Treat Rep"},{"key":"CR6","first-page":"1679","volume":"60","author":"AH Rossof","year":"1976","unstructured":"Rossof AH, Bearden JD, Cortman CA: Phase II evaluation of cis-diamminedichloroplatinum (II) in lung cancer. Cancer Treat Rep 60: 1679?1680, 1976","journal-title":"Cancer Treat Rep"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00165165","volume":"3","author":"J Kapp","year":"1985","unstructured":"Kapp J, Vance R: Supraophthalmic carotid infusion for recurrent gliomas: Rationale, technique, and preliminary results for cisplatin and BCNU. J Neuro-Oncol 3: 5?11, 1985","journal-title":"J Neuro-Oncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00406247","volume":"104","author":"K Kolaric","year":"1983","unstructured":"Kolaric K, Roth A, Jelicic I, Matkovic A: Phase II clinical trial of cis-dichlorodiammine platinum (CIS DDP) in metastatic brain tumors. J Cancer Res Clin Oncol 104: 287?293, 1983","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1200\/JCO.1988.6.1.62","volume":"6","author":"RW Walker","year":"1988","unstructured":"Walker RW, Allen JC: Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 6: 62?66, 1988","journal-title":"J Clin Oncol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00182958","volume":"1","author":"D Rosner","year":"1983","unstructured":"Rosner D, Nemoto T, Pickren J, Lane W: Management of brain metastases from breast cancer by combination chemotherapy. J Neuro-Oncol 1: 131?7, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/1097-0142(19860815)58:4<832::AID-CNCR2820580404>3.0.CO;2-W","volume":"58","author":"D Rosner","year":"1986","unstructured":"Rosner D, Nemoto T, Lane W: Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58: 832?9, 1986","journal-title":"Cancer"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archneur.1977.00500210025002","volume":"34","author":"NA Vick","year":"1977","unstructured":"Vick NA, Khandekar LD, Bigner DD: Chemotherapy of brain tumors: The blood-brain barrier is not a factor. Arch Neurol 34: 523?6, 1977","journal-title":"Arch Neurol"},{"key":"CR13","first-page":"753","volume":"60","author":"J Wolf","year":"1976","unstructured":"Wolf J: Nitrosourea as single agents in the treatment of pulmonary cancer. Cancer Treat Rep 60: 753?756, 1976","journal-title":"Cancer Treat Rep"},{"key":"CR14","first-page":"2474","volume":"42","author":"DJ Stewart","year":"1982","unstructured":"Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474?2479, 1982","journal-title":"Cancer Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00434394","volume":"5","author":"PE Gormley","year":"1981","unstructured":"Gormley PE, Gangji D, Wood JH, Poplack DG: Pharmaco-kinetic study of cerebrospinal fluid penetration of cis-diam-minedichloroplatinum (II). Cancer Chemother Pharmacol 5: 257?260, 1981","journal-title":"Cancer Chemother Pharmacol"},{"issue":"suppl 3","key":"CR16","first-page":"31","volume":"16","author":"DS Ettinger","year":"1989","unstructured":"Ettinger DS: Ifosfamide in the treatment of non-small lung cancer. Semin Oncol 16 (suppl 3): 31?38, 1989","journal-title":"Semin Oncol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/cdd.1983.1.69","volume":"1","author":"DE Lehane","year":"1983","unstructured":"Lehane DE, Bryan RN, Horowitz B, DeSantos L, Ehni G, Zubler MA, Moiel R, Rudolph L, Aldama-Leubbert A, Mahoney D, Harper R: Intraarterial cis-platinum chemotherapy for patients with primary and metastatic brain tumors. Cancer Drug Delivery 1: 69?77, 1983","journal-title":"Cancer Drug Delivery"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1097-0142(19840901)54:5<794::AID-CNCR2820540503>3.0.CO;2-F","volume":"54","author":"LG Feun","year":"1984","unstructured":"Feun LG, Wallace S, Stewart DJ, Chuang VP, Yung WKA, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Young SE, Tang RA, Handel S, Mavligit G, Fields WS: Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 54: 794?799, 1984","journal-title":"Cancer"},{"key":"CR19","first-page":"1844","volume":"28","author":"JZ Ginos","year":"1987","unstructured":"Ginos JZ, Cooper AJL, Dhawan V, Rottenberg DA: [13N]cisplatin PET to assess pharmacokinetics of intraarterial versus intravenous chemotherapy for malignant brain tumors. J Nucl Med 28: 1844?1852, 1987","journal-title":"J Nucl Med"},{"key":"CR20","first-page":"1877","volume":"49","author":"J Shani","year":"1989","unstructured":"Shani J, Bertram J, Russell C, Dahalan R, Chen DCP, Parti R, Ahmadi J, Kempf RA, Kawada TK, Mugia J, Wolf W: Noninvasive monitoring of drug biodistribution and metabolism: Studies with intraarterial Pt-195m-cisplatin in humans. Cancer Res 49: 1877?1881, 1989","journal-title":"Cancer Res"},{"key":"CR21","first-page":"917","volume":"43","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, Calvo D III, Samuels M, Bonura J, Loo TL: Clinical pharmacology of intraarterial cis-diamminedichloroplatinum (II). Cancer Res 43: 917?920, 1983","journal-title":"Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01324837.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01324837\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01324837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T09:42:27Z","timestamp":1556790147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01324837"}},"subtitle":["II: Clinical effects"],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["BF01324837"],"URL":"https:\/\/doi.org\/10.1007\/bf01324837","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}